Biblio
Export 1238 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is A [Clear All Filters]
“Association of Low Systolic Blood Pressure with Postmortem Amyloid-β and Tau.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1755-1764, 2020.
, “Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1713-1722, 2021.
, “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
, “Association of Motoric Cognitive Risk Syndrome with Cardiovascular Disease and Risk Factors: Results from an Original Study and Meta-Analysis.”, J Alzheimers Dis, vol. 64, no. 3, pp. 875-887, 2018.
, “Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.”, J Alzheimers Dis, vol. 63, no. 2, pp. 479-487, 2018.
, “Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.”, J Alzheimers Dis, vol. 53, no. 2, pp. 621-30, 2016.
, “Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.”, J Alzheimers Dis, vol. 53, no. 2, pp. 621-30, 2016.
, “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
, “Associations Between Local Area Deprivation and Physical Activity Participation in People with Cognitive Impairment in the North East of England.”, J Alzheimers Dis, vol. 95, no. 1, pp. 265-273, 2023.
, “Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1395-1408, 2016.
, “Associations Between Vascular Risk Factor and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.”, J Alzheimers Dis, vol. 89, no. 2, pp. 437-448, 2022.
, “Associations Between Vascular Risk Factor and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.”, J Alzheimers Dis, vol. 89, no. 2, pp. 437-448, 2022.
, “Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.”, J Alzheimers Dis, vol. 59, no. 2, pp. 695-705, 2017.
, “Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
, “Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
, “Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.”, J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
, “Astrocyte-neuron lactate transport is required for long-term memory formation.”, Cell, vol. 144, no. 5, pp. 810-23, 2011.
, “Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.”, J Alzheimers Dis, vol. 54, no. 1, pp. 135-48, 2016.
, “Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.”, J Alzheimers Dis, vol. 54, no. 3, pp. 941-955, 2016.
, “Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 87, no. 2, pp. 583-594, 2022.
, “Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1075-1089, 2022.
, “Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.”, J Alzheimers Dis, vol. 56, no. 1, pp. 403-413, 2017.
, “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
, “AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1109-23, 2016.
, “AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
,